What can we learn from COVID-19 vaccine R&D in China?: a discussion from a public policy perspective
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
25 February 2021
|
| In: |
Journal of travel medicine
Year: 2021, Volume: 28, Issue: 4, Pages: 1-3 |
| ISSN: | 1708-8305 |
| DOI: | 10.1093/jtm/taab026 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/jtm/taab026 Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/jtm/article/28/4/taab026/6149495 |
| Author Notes: | Yinglian Hu, PhD, and Simiao Chen, ScD |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1785976621 | ||
| 003 | DE-627 | ||
| 005 | 20230428030319.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220113s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/jtm/taab026 |2 doi | |
| 035 | |a (DE-627)1785976621 | ||
| 035 | |a (DE-599)KXP1785976621 | ||
| 035 | |a (OCoLC)1341436907 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hu, Yinglian |e VerfasserIn |0 (DE-588)124970071X |0 (DE-627)1786235102 |4 aut | |
| 245 | 1 | 0 | |a What can we learn from COVID-19 vaccine R&D in China? |b a discussion from a public policy perspective |c Yinglian Hu, PhD, and Simiao Chen, ScD |
| 246 | 3 | 0 | |a nineteen |
| 264 | 1 | |c 25 February 2021 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 17.01.2022 | ||
| 700 | 1 | |a Chen, Simiao |e VerfasserIn |0 (DE-588)1138719242 |0 (DE-627)896263061 |0 (DE-576)492659265 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of travel medicine |d Oxford : Oxford University Press, 1994 |g 28(2021), 4, Artikel-ID taab026, Seite 1-3 |h Online-Ressource |w (DE-627)34190760X |w (DE-600)2070527-X |w (DE-576)26347027X |x 1708-8305 |7 nnas |a What can we learn from COVID-19 vaccine R&D in China? a discussion from a public policy perspective |
| 773 | 1 | 8 | |g volume:28 |g year:2021 |g number:4 |g elocationid:taab026 |g pages:1-3 |g extent:3 |a What can we learn from COVID-19 vaccine R&D in China? a discussion from a public policy perspective |
| 856 | 4 | 0 | |u https://doi.org/10.1093/jtm/taab026 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://academic.oup.com/jtm/article/28/4/taab026/6149495 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220113 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 1138719242 |a Chen, Simiao |m 1138719242:Chen, Simiao |d 910000 |d 912800 |e 910000PC1138719242 |e 912800PC1138719242 |k 0/910000/ |k 1/910000/912800/ |p 2 |y j | ||
| 999 | |a KXP-PPN1785976621 |e 4034520809 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title":"What can we learn from COVID-19 vaccine R&D in China?","subtitle":"a discussion from a public policy perspective","title_sort":"What can we learn from COVID-19 vaccine R&D in China?"}],"language":["eng"],"person":[{"display":"Hu, Yinglian","given":"Yinglian","role":"aut","family":"Hu"},{"display":"Chen, Simiao","role":"aut","given":"Simiao","family":"Chen"}],"name":{"displayForm":["Yinglian Hu, PhD, and Simiao Chen, ScD"]},"id":{"doi":["10.1093/jtm/taab026"],"eki":["1785976621"]},"physDesc":[{"extent":"3 S."}],"note":["Gesehen am 17.01.2022"],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisher":"Oxford University Press ; Decker Periodicals ; Blackwell Publ. ; Wiley-Blackwell","dateIssuedDisp":"1994-","dateIssuedKey":"1994","publisherPlace":"Oxford ; Hamilton, Ont. ; Oxford [u.a.] ; Oxford [u.a.]"}],"recId":"34190760X","disp":"What can we learn from COVID-19 vaccine R&D in China? a discussion from a public policy perspectiveJournal of travel medicine","id":{"eki":["34190760X"],"issn":["1708-8305"],"zdb":["2070527-X"],"doi":["10.1111/(ISSN)1708-8305"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 10.02.2020","Fortsetzung der Druck-Ausgabe"],"name":{"displayForm":["official publication of the International Society of Travel Medicine and the Asia Pacific Travel Health Association"]},"pubHistory":["1.1994 -"],"title":[{"title_sort":"Journal of travel medicine","title":"Journal of travel medicine"}],"part":{"issue":"4","extent":"3","pages":"1-3","volume":"28","year":"2021","text":"28(2021), 4, Artikel-ID taab026, Seite 1-3"},"language":["eng"]}],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"25 February 2021"}],"recId":"1785976621","type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a HUYINGLIANWHATCANWEL2520 | ||